Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 16154-62-4 | MDL No. : | MFCD00030787 |
Formula : | C11H14ClN3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UFFIYCVVTWWGGH-UHFFFAOYSA-N |
M.W : | 255.70 | Pubchem ID : | 2837294 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.45 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 76.53 |
TPSA : | 52.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.22 cm/s |
Log Po/w (iLOGP) : | 2.29 |
Log Po/w (XLOGP3) : | 2.31 |
Log Po/w (WLOGP) : | 1.24 |
Log Po/w (MLOGP) : | 1.18 |
Log Po/w (SILICOS-IT) : | -0.07 |
Consensus Log Po/w : | 1.39 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.01 |
Solubility : | 0.25 mg/ml ; 0.000978 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.05 |
Solubility : | 0.23 mg/ml ; 0.000898 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.57 |
Solubility : | 0.693 mg/ml ; 0.00271 mol/l |
Class : | Soluble |
PAINS : | 1.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.32 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | for 1 h; | Preparation 1 1-(2-Chloro- -nitrophenyl)-4-methylpiperazine: 4-methylpiperizine (17.2 g, 172 mmol) was added to a flask containing 2-chloro-1-fluoro-4-nitrobenzene (10.05 g, 57.2 mmol). The reaction exothermed and was stirred for one hour before being treated with water. The resulting precipitate was collected by filtration, washed with water, and air dried to give the title compound as a brown solid (14.1 g, 96percent). 1H NMR (400 MHz, DMSO-de) δ ppm 2.24 (s, 3 H) 2.43 - 2.55 (m, 4 H) 2.43 - 2.55 (m, 4 H) 3.11 - 3.24 (m, 4 H) 7.28 (d, J=9.03 Hz, 1 H) 8.14 (dd, J=9.03, 2.76 Hz, 1 H) 8.21 (d, J=2.51 Hz, 1 H); MS (m/z) 255 (M+ + . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With hydrogen In methanol for 48 h; | [3-Chloro-4-(4-methyl-1-piperazinyl)phenyl]amine: 1-(2-chloro-4-nitrophenyl)-4- methylpiperazine (13.5 g, 52.8 mmol) was dissolved in Methanol (200 mL), and treated with platinum(IV) oxide (0.120 g, 0.528 mmol). The reaction was evacuated and back filled with H2 twice, then stirred for 48 hours under an H2 atmosphere. The crude mixture was filtered through a pad of celite, washed with MeOH, and concentrated to give the title compound as an orange solid (12 g, 100percent). 1H NMR (400 MHz, METHANOL-^) δ ppm 2.35 (s, 3 H) 2.62 (br. s., 4 H) 2.95 (br. s., 4 H) 6.63 (dd, J=8.53, 2.76 Hz, 1 H) 6.75 - 6.81 (m, 1 H) 6.90 - 6.97 (m, 1 H); MS (m/z) 226 (M+H+). |
98% | With platinum(IV) oxide; hydrogen In methanol at 20℃; for 5 h; | 3-Chloro-4-(4-methylpiperazin-l-yl)aniline (SG4-030): To a solution of SG4-029 (2.00 g, 7.82 mmol) in MeOH (32 niL, deoxygenated with Argon gas) was added PtC (18 mg, 0.0782 mmol). A balloon of hydrogen gas was attached to the flask via a septum cap. The mixture was stirred at room temperature for 5 h. The reaction mixture was filtered over Celite and the filtrate concentrated under reduced pressure to provide the title compound as a light yellow solid (1.741 g, 98percent). NMR (400 MHz, DMSO-) δ: 6.85 (d, J= 8.5 Hz, 1H), 6.59 (d, J= 2.6 Hz, 1H), 6.45 (dd, J= 8.5, 2.6 Hz, 1H), 5.01 (s, 2H, disappeared on D2O shake), 2.81- 2.72 (m, 4H), 2.40 (brs, 4H), 2.18 (s, 3H). HPLC-MS (ESI+): m/z 228.2 [35percent, (M37C1+H)+], 226.2 [100percent, (M35C1+H)+]. |
98% | With platinum(IV) oxide; hydrogen In methanol at 20℃; for 5 h; Inert atmosphere | To a solution of SG4-029 (2.00 g, 7.82 mmol) in MeOH (32 mL, deoxygenated with Argon gas) was added PtC (18 mg, 0.0782 mmol). A balloon of hydrogen gas was attached to the flask via a septum cap. The mixture was stirred at room temperature for 5 h. The reaction mixture was filtered over Celite and the filtrate concentrated under reduced pressure to provide the title compound as a light yellow solid (1.741 g, 98percent). NMR (400 MHz, DMSO-ifc) δ: 6.85 (d, J = 8.5 Hz, 1H), 6.59 (d, / = 2.6 Hz, 1H), 6.45 (dd, / = 8.5, 2.6 Hz, 1H), 5.01 (s, 2H, disappeared on D20 shake), 2.81- 2.72 (m, 4H), 2.40 (brs, 4H), 2.18 (s, 3H). HPLC-MS (ESI+): m/z 228.2 [35percent, (M37C1+H)+], 226.2 [100percent, (M35C1+H)+]. |
[ 23008-56-2 ]
N-(4-Chlorophenyl)-2-nitroaniline
Similarity: 0.81
[ 25781-92-4 ]
5-Chloro-2-nitro-N-phenylaniline
Similarity: 0.80
[ 15950-17-1 ]
4-Chloro-N-methyl-2-nitroaniline
Similarity: 0.78
[ 1052538-72-3 ]
3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride
Similarity: 0.77
[ 23008-56-2 ]
N-(4-Chlorophenyl)-2-nitroaniline
Similarity: 0.81
[ 25781-92-4 ]
5-Chloro-2-nitro-N-phenylaniline
Similarity: 0.80
[ 15950-17-1 ]
4-Chloro-N-methyl-2-nitroaniline
Similarity: 0.78
[ 1052538-72-3 ]
3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride
Similarity: 0.77
[ 23008-56-2 ]
N-(4-Chlorophenyl)-2-nitroaniline
Similarity: 0.81
[ 25781-92-4 ]
5-Chloro-2-nitro-N-phenylaniline
Similarity: 0.80
[ 15950-17-1 ]
4-Chloro-N-methyl-2-nitroaniline
Similarity: 0.78
[ 16154-72-6 ]
3-Chloro-4-(4-methylpiperazin-1-yl)benzenamine
Similarity: 0.77
[ 1052538-72-3 ]
3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride
Similarity: 0.77
[ 5521-38-0 ]
2-(4-(4-Nitrophenyl)piperazin-1-yl)ethanol
Similarity: 0.73
[ 23491-48-7 ]
5-(4-Methylpiperazin-1-yl)-2-nitroaniline
Similarity: 0.73
[ 5367-58-8 ]
5-Nitro-2-(piperidin-1-yl)aniline
Similarity: 0.68
[ 16154-72-6 ]
3-Chloro-4-(4-methylpiperazin-1-yl)benzenamine
Similarity: 0.77
[ 1052538-72-3 ]
3-Chloro-4-(4-methylpiperazin-1-yl)aniline hydrochloride
Similarity: 0.77
[ 5521-38-0 ]
2-(4-(4-Nitrophenyl)piperazin-1-yl)ethanol
Similarity: 0.73
[ 23491-48-7 ]
5-(4-Methylpiperazin-1-yl)-2-nitroaniline
Similarity: 0.73